| Application no. and date | 09721669.1 (espacenet) (Federated) (European Patent Register), 20090316 | | Patent/reg. no. and date | DK/EP 2271363, 20170503 | | Publication date | 20110112 | | Priority no. and date | US 69841 P, 20080317 | | EP pub. no. and date |
EP 2271363 20110112 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku
Osaka-Shi, Osaka, JP | | Applicant ref. no. | 6.1706.012 | | Inventor | FROST, Gregory, I., 13662 Mercado Drive
Del Mar, CA 92014, US,
LEIBL, Heinz, Kininger Gasse 12
A-1120 Vienna, AT,
SCHIFF, Richard, 2878 Raccoon Point Way
Eastsound WA 98245, US | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 38/47 (2006.01) , A61K 39/395 (2006.01) , A61P 37/00 (2006.01) , C07K 16/06 (2006.01) , C12N 9/26 (2006.01) | | Title | KOMBINATIONER OG FREMGANGSMÅDER TIL SUBKUTAN ADMINISTRATION AF IMMUNGLOBULIN OG HYALURONIDASE | | Int. application no. | US2009001670 | | Int. publication no. | WO2009117085 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
